yahoofinance on Nostr: NewAmsterdam Pharma (NAMS) Wins EU Approvals. Can Cholesterol Pills Drive Royalties? NewAmsterdam Pharma (NAMS) Wins EU Approvals. Can Cholesterol Pills Drive Royalties?https://finance.yahoo.com/healthcare/articles/newamsterdam-pharma-nams-wins-eu-012024900.html